SEC Tracker
Get the app
UTMD · XBRL financial data

Utah Medical Products financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (UTMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers12,50512,33311,34010,40010,0059,1579,7109,9539,8129,0448,7228,529
Cost of goods and services sold5,1465,235*4,5744,1474,2033,835*4,1724,3584,2083,781*3,4403,771
Gross profit7,3597,0986,7666,2535,8025,3235,5385,5955,6045,2645,2824,758
Research and development138146*266255172121*154135167212*154154
Selling, general and administrative3,252—2,6172,5602,287—2,2312,2642,826—2,5631,955
General and administrative—year only———year only———year only——
Total operating expenses3,390—2,8832,8152,459—2,3852,3992,993—2,7172,109
Operating income (loss)3,9693,944*3,8833,4383,3432,930*3,1533,1962,6112,441*2,5652,649
Other income (expense)812(1,983)*915773836(2,698)*705640698(2,163)*617637
Income tax expense (benefit)846731*842758616712*817788678540*578600
Earnings per share, basic USD per share1.08—1.090.981.02—0.920.940.82—0.820.84
Earnings per share, diluted USD per share1.081.181.090.981.020.860.920.940.820.800.820.84
Weighted average shares, basic thousands of shares3,6293,631*3,6183,5323,4783,386*3,3103,2463,2073,199*3,1853,184
Weighted average shares, diluted thousands of shares3,6393,634*3,6183,5323,4783,386*3,3103,2463,2073,199*3,1853,184

Balance sheet

CSV

Fiscal quarters (UTMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents88,20992,86893,80889,21988,45282,97683,32582,17984,26785,75687,40687,528
Accounts receivable3,4873,3913,5913,6683,7204,0943,9443,6323,7253,5223,6363,565
Inventory9,7099,5829,2409,0589,1078,8128,6488,2338,1187,9358,7229,003
Total current assets101,847106,269107,149102,322101,65696,33096,39994,37596,53297,742100,378100,639
Property and equipment, net10,34610,55110,26610,19410,4199,7639,94510,25710,0009,9089,7219,631
Right-of-use asset—342———338———286——
Goodwill13,42413,69213,63813,64014,02713,58013,77014,19314,05114,05213,91913,956
Total assets131,243135,458135,441130,032129,694122,538122,519120,802121,975122,542124,382124,572
Accounts payable5117699988349996969147377689111,194876
Accrued liabilities3,6663,9414,4763,1052,4363,0613,4101,5172,2431,6872,3111,194
Total current liabilities4,1774,7105,4743,9393,4353,7574,3242,2543,0112,5983,5052,070
Lease liability, non-current305295285275299282———226——
Total liabilities7,5417,1457,6995,9805,4975,1115,4723,2693,7233,2744,0092,539
Retained earnings135,144138,341138,995135,339134,053129,302128,204126,863127,958128,652130,260131,954
Total stockholders' equity123,702128,313127,742124,052124,197117,427117,047117,533118,252119,268120,373122,033
Total liabilities and equity131,243135,458135,441130,032129,694122,538122,519120,802121,975122,542124,382124,572
Common shares outstanding (cover page) thousands of shares3,6303,5893,5283,4773,3923,2823,2483,2063,2043,1853,1843,184

Cash flows

CSV

Fiscal quarters (UTMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Stock-based compensation53*72*7952*53*72*8286*94*111*12072*
Net cash from operating activities5,121*5,332*5,2762,762*3,856*2,937*4,4642,873*3,878*3,477*3,1091,383*
Purchases of property and equipment186*90*22110*89*9*18451*27*109*130134*
Net cash from investing activities(186)*(90)*5(115)*(89)*(9)*(184)(51)*(27)*(109)*(130)(134)*
Proceeds from issuing common stock36*0*96294*0*0*00*0*0*——
Share repurchases0*0*2,9906,403*3,866*6,709*3,2213,487*653*994*12878*
Dividends paid1,071*1,071*1,0891,081*1,052*1,038*1,0171,001*988*977*989987*
Net cash from financing activities(1,035)*(1,071)*(3,983)(7,190)*(4,918)*(7,747)*(4,238)(4,488)*(1,641)*(1,971)*(1,117)(1,065)*
Net change in cash3,590*4,659*940(4,589)*(767)*(5,476)*349(1,146)*2,088*1,489*1,650122*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Utah Medical Products87,5288,5291,383*3.2M— 10-QJun 30, 2026
SkinHealth Systems206,07472,1132,671*130.1M— 10-QJun 30, 2026
Sight Sciences79,75323,388(5,663)*55.1M14.1 quarters 10-QJun 30, 2026
Profound Medical38,2712,483(11,338)*36.5M3.4 quarters 10-QJun 30, 2026
Stereotaxis10,4917,670(3,675)*100.2M2.9 quarters 10-QJun 30, 2026
Inogen87,27695,0842,946*26.5M— 10-QJun 30, 2026
Semler Scientific10,1767,491(32,950)*15.2M0.3 quarters 10-QSep 30, 2025
Sanara MedTech15,42128,1372,038*9.2M— 10-QJun 30, 2026
Anika Therapeutics38,41232,610(684)*13.4M56.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.